Statements (51)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:database
|
| gptkbp:covers |
global drug development
|
| gptkbp:focusesOn |
pharmaceutical drug development
|
| https://www.w3.org/2000/01/rdf-schema#label |
Pharmaprojects
|
| gptkbp:includes |
discontinued drugs
marketed drugs preclinical drugs withdrawn drugs |
| gptkbp:launched |
1986
|
| gptkbp:ownedBy |
gptkb:Citeline
|
| gptkbp:previousOwner |
gptkb:Informa
|
| gptkbp:provides |
clinical trial information
regulatory status route of administration company and licensing information company pipeline analysis development phase drug accelerated approval status drug adverse event data drug approval dates drug approval status drug breakthrough therapy status drug delivery technology drug development timelines drug fast track status drug formulation data drug indication data drug launch dates drug manufacturer information drug market withdrawals drug orphan designation drug patent information drug pipeline data drug priority review status drug regulatory submissions drug safety data drug sales forecasts drug status updates drug target information drug trial outcomes licensing opportunities mechanism of action data molecular type classification therapeutic area classification |
| gptkbp:usedBy |
investors
academic researchers pharmaceutical companies biotechnology companies |
| gptkbp:website |
https://pharmaintelligence.informa.com/products-and-services/data-and-analysis/pharmaprojects
|
| gptkbp:bfsParent |
gptkb:STN_International
|
| gptkbp:bfsLayer |
6
|